CICC Wealth Investment's dealings in Yichang HEC shares disclosed

According to a disclosure made on June 25, 2025, CICC Wealth Investment Limited engaged in both sales and purchases of "other types of securities" related to YiChang HEC ChangJiang Pharmaceutical shares. These transactions, conducted on June 24, 2025, involved the creation of Delta 1 products from wholly unsolicited client-driven orders and client facilitation trades in ordinary shares arising from wholly unsolicited client-driven orders. The firm sold 1,200 shares for a total of USD 16,721.7000, with prices received ranging from USD 13.9348. Simultaneously, it purchased 1,200 shares for USD 16,703.1000, at prices between USD 13.9193. CICC Wealth Investment Limited affirmed that any resultant proprietary positions from client facilitation trades would be flattened by the end of the next trading day's morning session.